Related Experiment Video

Updated: Jun 12, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

[The heart of a patient with type 1 diabetes]

S Lacigová1, J Meinlová, J Gruberová

  • 1I. interní klinika Lékarské fakulty UK a FN Plzen. lacigova@fnplzen.cz

Vnitrni Lekarstvi
|June 29, 2010
PubMed

Insights

Type 1 diabetes patients face risks of heart issues like ischemic heart disease and diabetic cardiomyopathy, often occurring together. Early cardiology assessment is crucial for diagnosing, preventing, and treating these cardiovascular diseases.

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Context:

  • Type 1 diabetes (T1D) significantly increases the risk of cardiovascular complications.
  • Heart conditions in T1D patients include ischemic heart disease, cardiovascular autonomic neuropathy, and diabetic cardiomyopathy.
  • These conditions often coexist and share common risk factors, complicating patient management.

Purpose:

  • To provide a comprehensive overview of diagnostic, preventive, and therapeutic strategies for heart diseases in T1D.
  • To highlight the importance of regular cardiology assessments for T1D patients due to high cardiovascular mortality.
  • To consolidate information on these specific cardiac comorbidities in a structured format.

Summary:

  • This review synthesizes current knowledge on diagnosing, preventing, and treating ischemic heart disease, cardiovascular autonomic neuropathy, and diabetic cardiomyopathy in type 1 diabetes.
  • It emphasizes the combined impact of these conditions and their shared risk factors.
  • Each cardiac condition is addressed in a dedicated chapter for clarity.

Impact:

  • Enhances understanding of cardiovascular risks associated with type 1 diabetes.
  • Informs clinical practice regarding the screening, diagnosis, and management of heart disease in T1D.
  • Underscores the critical need for proactive cardiology involvement in T1D care to reduce mortality.

More Related Videos

Isolation of Human Islets from Partially Pancreatectomized Patients11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...